As per Jasper Colin’s recently conducted study, the global RWE market is expected to reach $5.2 billion by 2030, with a growth rate of 13.9%. This growth is driven by the growing availability of RWD and its adoption by pharmaceutical companies and healthcare providers for a deeper understanding of patient data.

1. Real-World Data (RWD) and Real-World Evidence
(RWE) are revolutionizing healthcare by providing
evidence and insights from real-life experiences.
This helps healthcare stakeholders make informed
decisions and result in improved patient outcomes.
As per Jasper Colin’s recently conducted study, the
global RWE market is expected to reach $5.2 billion
by 2030, with a growth rate of 13.9%. This growth
is driven by the growing availability of RWD and its
adoption by pharmaceutical companies and
healthcare providers for a deeper understanding of
patient data.
Interpreting the value proposition of
RWD/RWE Data